Impact of perioperative chemotherapy on survival outcomes in patients with non-small cell lung cancer undergoing pneumonectomy: a SEER database analysis

Read full text Summarise with VIRAT
Authors: Zhilong Xu, Ao Zeng, Yanze Yin, Keyi Chen, Abudumijiti Abuduwayiti, Jiarui Wang, Mengtao Wang, Ming Liu, Gening Jiang, Jie Dai
Cited by: 0
References: 34

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Pneumonectomy for locally advanced non-small cell lung cancer (NSCLC) carries significant risk. While perioperative chemotherapy is standard for multimodality treatment, its specific impact on long-term survival in this high-risk surgical cohort is not well-defined. This study aims to evaluate the impact of chemotherapy on long-term survival in patients with locally advanced NSCLC undergoing pneumonectomy. Methods: Data from 640 patients with T3-4N0-3M0 NSCLC who underwent pneumonectomy were extracted from the Surveillance, Epidemiology, and End Results (SEER) database (2007-2021). Patients were grouped by chemotherapy receipt and analyzed for the timing of chemotherapy. Propensity score matching (PSM) was applied to balance baseline differences. Survival outcomes were analyzed using Cox regression and subgroup interaction analyses. Results: 20.0 months, P

Fields of Study & Subjects

Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies Lung Cancer Treatments and Mutations

Publication details

Journal / source
Journal of Thoracic Disease
Volume
18
Issue
3
Pages
232–232
Publication date
1 March 2026
Language
EN